Using nationally representative serial cross-sectional data from the 2006–18 National Ambulatory Medical Care Surveys regarding visits to outpatient primary care physicians by patients ages ...

During the trial, the majority of patients, 77%, were treated with alglucosidase alfa before entering the trial for a median duration of 7.4 years. Patients who continued with alglucosidase alfa plus ...